Detection of liver fibrosis stages in patients with hepatitis C virus infection by non-invasive tool (original) (raw)

Novel Serum Markers of Fibrosis Progression for the Follow-Up of Hepatitis C Virus-Infected Patients

Odile Goria

The American Journal of Pathology, 2009

View PDFchevron_right

Fibrosis markers in hepatitis C

KEYUR PATEL

Current Hepatitis Reports, 2006

View PDFchevron_right

Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients

Ryosuke Tateishi

View PDFchevron_right

Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma

Raafat Ibrahim

Molecular Biology Reports, 2012

View PDFchevron_right

Evaluation of the Expression of c-MYC Protein during Liver Fibrosis Progression in Chronic Hepatitis Developed by Hepatitis C Virus Infected Patients

Shigueko Sonohara

Journal of Carcinogenesis & Mutagenesis, 2014

View PDFchevron_right

Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C

Valérie Paradis

Gastroenterology, 2005

View PDFchevron_right

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

Joseph Moussalli

Journal of Viral Hepatitis, 2002

View PDFchevron_right

The process of liver fibrosis in chronic hepatitis C - histological and immunohistochemical study

Oana Badea

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2018

View PDFchevron_right

Hepatitis C virus proteins do not directly trigger fibrogenic events in human liver myofibroblasts

Kelly Tan

Journal of Hepatology, 2002

View PDFchevron_right

FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection

Rabab Fouad

Arab Journal of Gastroenterology, 2016

View PDFchevron_right

Histological factors that predict the liver fibrosis in patients with chronic hepatitis C

Mircea-Catalin Fortofoiu

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2016

View PDFchevron_right

S100A14 protein as diagnostic and prognostic marker in hepatocellular carcinoma

Mohamed Serag

Egyptian Liver Journal, 2019

View PDFchevron_right

Discovery of Novel Biomarker Candidates for Liver Fibrosis in Hepatitis C Patients: A Preliminary Study

Abhinav Kumar

PLoS ONE, 2012

View PDFchevron_right

Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study

Ahmad Fouad

International Journal of General Medicine, 2013

View PDFchevron_right

Role of assessing liver fibrosis in management of chronic hepatitis C virus infection

Irene Cuenca

Clinical Microbiology and Infection, 2016

View PDFchevron_right

Fibrosis in liver as a predictive marker for hepatitis C virus therapy

Akif Altinbas

2010

View PDFchevron_right

Novel Serum Biomarker Candidates for Liver Fibrosis in Hepatitis C Patients

Nicole Zitzmann

Clinical Chemistry, 2007

View PDFchevron_right

Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C

Fabiano Perdigao

PLOS ONE, 2015

View PDFchevron_right

Non-invasive predictive score of fibrosis stages in chronic hepatitis C patients based on epithelial membrane antigen in the blood in combination with routine laboratory markers

Khaled Farid, Abdelfattah Attallah

Hepatology Research, 2011

View PDFchevron_right

Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients

Zehra Akpinar, Mahmut Arabul

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2012

View PDFchevron_right

Role of simple biomarkers in predicting fibrosis progression in HCV infection

Shu-yuan Xiao

World Journal of Gastroenterology, 2010

View PDFchevron_right

Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients

Mohamed Abdallah

Annals of hepatology

View PDFchevron_right

Clinical and epidemiological overview of liver fibrosis and hepatocellular carcinoma in patients infected with the hepatitis C virus

Patricia Moura

Research, Society and Development, 2020

View PDFchevron_right

Assessment of Fibrosis in Cases with Hepatitis C Infection ; a Comparative Study Between Liver Transient Elastography and Liver Biopsy ( using Routine and Immunohistochemical Staining )

Kamal A El-Atrebi

2015

View PDFchevron_right

Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study

Dina Sabry Abdel Fatah Hamed

International Journal of General Medicine, 2013

View PDFchevron_right

Activated Hepatic Stellate Cells (Ito Cells) - Marker of Advanced Fibrosis in Chronic Viral Hepatitis C: A Pilot Study

Toader Zaharie

Journal of Gastrointestinal and Liver Diseases

View PDFchevron_right

Noninvasive assessment of liver fibrosis in chronic hepatitis C infection

KEYUR PATEL

Current Hepatitis Reports, 2008

View PDFchevron_right

Fibrosis and disease progression in hepatitis C

Nathalie Boyer

Hepatology, 2002

View PDFchevron_right

Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection

Wafaa Elakel, Olfat Shaker

View PDFchevron_right

Validation of Three Non-Invasive Markers in Assessing the Severity of Liver Fibrosis in Chronic Hepatitis C

Samiullah Shaikh

View PDFchevron_right